Medicine News

Arthur Hayes, freshly pardoned by US President Donald Trump, has taken a board seat and major stake in a stem cell company where he’s also been a patient.

Crypto-funded DeSci group HydraDAO said its researchers restored mobility in rats with severed spines within five days using a novel PEG-chitosan compound.

Atai Life Sciences founder Christian Angermayer says holding Bitcoin could be a way for biotech firms to survive the blisteringly long approval process required to bring their drugs to market.

Pump Science partially blamed Solana-based software firm BuilderZ for leaving the private key to the dev wallet address on GitHub for the public to see.

Mechanism Capital’s Andrew Kang said DeSci protocols will likely change their existing models before evolving into more market-ready products.

DeSci advocates say “traditional science” has fallen prey to regulatory capture and been maligned by corporate greed, and now a blockchain-based update is in order. 

Medicine is leading the charge toward decentralized science — here’s why.

Neurotech firm Synchron has integrated OpenAI’s generative AI tech into its brain-computer interface to help severely paralyzed patients communicate again.

The metaverse has found substantial footing in the medical industry with the advent of dedicated facilities catering to remote healthcare.

Digital security has become a paramount concern for the medical industry in the wake of the 2017 “WannaCry” cyberattack.

The first Neuralink product will be called “Telepathy,” according to Musk, allowing users to control digital devices using only their thoughts.

LLM 4.0 from OpenAI answered 85% of the American Board of Psychiatry and Neurology’s questions correctly, implying potentially “significant” future uses for the technology.

The collaboration aims to create a zero-shot generative AI model that would work on creating new antibody therapeutics and enhancing existing ones.

The COVID-19 pandemic significantly increased broad-spectrum antibiotic prescriptions, leading to antibiotic resistance development within superbugs.

VitaDAO community agreed to fund early-stage cancer research through the launch of a biotech company named Matrix Biosciences.